Brian Taylor Slingsby - Director, 10%+ Owner at Mineralys Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director, 10%+ Owner
Issuer Symbol
MLYS on Nasdaq
All Insider Reports
All Insider Reports

Brian Taylor Slingsby - trading volume in the past year for Mineralys Therapeutics, Inc.

Holdings reported by Brian Taylor Slingsby for Mineralys Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 7,903,838 $342,631,377 $43.35 20 Nov 2025 Indirect
Stock Option 32,900 13 Feb 2025 Indirect Common Stock
Stock Option 0 13 Feb 2025 Direct Common Stock

Transactions reported by Brian Taylor Slingsby for Mineralys Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.